from biddaddyalso.......after reading the meta study y'all named i decided to do the switch, as the ONC suggested, pending ok from cardio. info lacking in summary IE: who are subjects incomplete so unsure if my CHF is included and and etc?. but writer clear about the relative disadvantages of agonists (LUPRON)over time. i did not read yet any of the studies referenced. also, there is a risk with orgovyx related to "long QT syndrome"
a restraint to orgovyx is cost. 2k monthly. with medicare DR. Google say $100 mthy. add the NUBEQA , well do the math. this year. max out of pocket drog is $2,100, of this i am certain. otherwise i couldnot afford.